No Data
Bristol-Myers Squibb Options Spot-On: On March 25th, 59,262 Contracts Were Traded, With 510.14K Open Interest
Press Release: 2seventy Bio Reports Fourth Quarter and Full Year 2024 Financial Results
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says
Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
J.P. Morgan Maintains Bristol-Myers Squibb(BMY.US) With Buy Rating, Maintains Target Price $70
